|
1 |
08 12 2025 |
India exploring possibilities to expand WHO benchmarking standards for Indian medicines |
Pharmabiz |
India |
|
2 |
08 12 2025 |
IPC to revive focus on strengthening pharmacovigilance and materiovigilance in the NE region |
Pharmabiz |
India |
|
3 |
08 12 2025 |
US FDA fortifies regulatory alliance with Telangana DCA in Hyderabad |
Pharmabiz |
India |
|
4 |
08 12 2025 |
Import of bulk drugs and intermediates declines over 11% in October |
Pharmabiz |
India |
|
5 |
08 12 2025 |
Unani manufacturers urge the community to modernize and complete with Pharma giants |
News meter |
India |
|
6 |
08 12 2025 |
Mandatory QR Code for med allergic reactions: Pharma body to start drive |
Times of India |
India |
|
7 |
08 12 2025 |
State cabinet approves Odisha Pharma. Medtech policy to build sector hubs |
Health world (Economic Times) |
India |
|
8 |
06 12 2025 |
India renew engagement strategy with CEPI for cooperation on vaccine ,allied technology RnD |
Medical Dialogues |
India |
|
9 |
06 12 2025 |
Chhattisgarh clears over Rs.46 crore for new drug testing lab and FDA building. |
Medical Dialogues |
India |
|
10 |
06 12 2025 |
Same Brand name used for Multiple Drugs: Government panel calls for Stakeholder consultation. |
Medical Dialogues |
India |
|
11 |
06 12 2025 |
WHO alerts Spurs India’s probe into Deadly cough syrup ,License cancelled,700 plus united audited ,parliament informed. |
Medical Dialogues |
India |
|
12 |
06 12 2025 |
CDSCO panel seeks protocol revisions in Levim Lifetech’s Teriparatide Biosimilar study. |
Medical Dialogues |
India |
|
13 |
06 12 2025 |
Senores Pharma gets Philippine FDA approval for basket of 10 products. |
Medical Dialogues |
India |
|
14 |
06 12 2025 |
Pharma sector braces for mixed impact as rupee breaches Rs. 90 mark against US dollar |
Pharmabiz |
India |
|
15 |
06 12 2025 |
India’s BioE3 & RDI push to transform innovation & bio manufacturing ecosystem: Anand Nambiar |
Pharmabiz |
India |
|
16 |
06 12 2025 |
BDCDA asks cos to strengthen ethical pharma distribution to end exploitation of credit structures |
Pharmabiz |
India |
|
17 |
06 12 2025 |
AIOCD enforces mandatory 'MRP Minus 25%' rule for LBE claims to protect chemist margins |
Pharmabiz |
India |
|
18 |
05 12 2025 |
USFDA – Telangana DCA meet to discuss future activities |
Medical Dialogues |
India |
|
19 |
05 12 2025 |
Indian pharma ramps up global alignment, enforces strict ICH & WHO standards |
Pharmabiz |
India |
|
20 |
05 12 2025 |
Haryana DCA focuses on quality overhaul, inspectors trained for revised Schedule M audits |
Pharmabiz |
India |
